Generieke Naam
|
Merkenaam/
Alternatieve naam
|
Expressiesysteem
|
Indicaties
|
Fabrikant
|
Onderzoeks- en Ontwikkelingsfase
|
Recombinant interferon β-1b
|
Betaseron, 倍泰龙
|
Escherichia coli (E. coli)
|
Multiple sclerose (MS)
|
Bayer AG
|
Goedkeuring
|
Recombinant menselijk interferon β-1b
|
Extavia, ベタフェロン
|
E. coli
|
Multiple sclerose (MS)
|
Novartis AG
|
Goedkeuring
|
interferon β-1b
|
Actoferon
|
Wacht op update
|
Multiple sclerose (MS)
|
AMEGA Biotech
|
Goedkeuring
|
interferon β-1b
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Biocad
|
Goedkeuring
|
Recombinant menselijk interferon β-1b
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Internationaal Biotech Centrum Generium
|
Goedkeuring
|
interferon β-1b
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Pressure BioSciences
|
Fase III
|
interferon β-1b
|
Rec Hu-IFN beta 1a-44 microgram, ReciGen
|
Wacht op update
|
Multiple sclerose (MS)
|
Cinnagen
|
Fase III
|
interferon β-1b
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Probiomed SA de CV
|
Goedkeuring
|
interferon β-1b
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Bio-Ker s.r.l.
|
Pre-klinisch
|
Polyethyleenglycol recombinant interferon β
|
Peginterferon beta
|
Wacht op update
|
Multiple sclerose (MS)
|
Merck, Ambrx Biopharma
|
Pre-klinisch
|
Recombinant menselijk interferon β-1a
|
Blastoferon
|
Wacht op update
|
Multiple sclerose (MS)
|
Biosidus
|
Goedkeuring
|
Recombinant menselijk interferon β-1a
|
Interferon beta-1a, PLEGRIDY, BG-9418, Avonex, アボネックス
|
CHO cel
|
Multiple sclerose (MS)
|
Biogen, Inc., Eisai Co.,
|
Goedkeuring
|
Polyethyleenglycol recombinant interferon β-1a
|
Peginterferon beta-1a, Plegridy, BIIB-017
|
CHO cel
|
Multiple sclerose (MS)
|
Biogen, Inc., Eisai Co., Ltd., UCB SA
|
Goedkeuring
|
Recombinant menselijk interferon β-1a
|
REBIF
|
CHO cel
|
Multiple sclerose (MS)
|
Merck, FLAMEL IRELAND LTD, Serono Pharma Schweiz, Pfizer
|
Goedkeuring
|
interferon β-1a
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Insight Biopharmaceuticals Ltd.
|
Goedkeuring
|
interferon β-1a
|
Xerfelan
|
Wacht op update
|
Multiple sclerose (MS)
|
Landsteiner Scientific SA de CV
|
Goedkeuring
|
Recombinant menselijk interferon β-1a
|
Interferon bèta-1a
|
Wacht op update
|
Multiple sclerose (MS)
|
Reliance Life Sciences
|
Goedkeuring
|
interferon β-1a
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Probiomed SA de CV
|
Goedkeuring
|
Peginterferon bèta-1a
|
Cinnaferon
|
Wacht op update
|
Multiple sclerose (MS)
|
Cinnagen
|
Fase III
|
interferon β-1a
|
FP-1201, FP-1201-lyo, MR-11A8, Traumakine
|
Wacht op update
|
Multiple sclerose (MS)
|
Lee's Pharmaceutical
|
Fase III
|
Sampeginterferon beta-1a
|
TENEXIA, BCD 054, BCD-054
|
Wacht op update
|
Multiple sclerose (MS)
|
Biocad
|
Fase III
|
interferon β-1b
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Pfenex, Inc.
|
Fase I
|
Interferon beta-1a verlengde uitkomst
|
Wacht op update
|
Wacht op update
|
Multiple sclerose (MS)
|
Weizmann Institute of Science
|
Fase I
|
Recombinant menselijk interferon β-1a
|
Interferon bèta-1a
|
Wacht op update
|
Multiple sclerose (MS)
|
Cinnagen
|
Fase I
|
Pegylated interferon β
|
TRK-560, PEG-IFN-beta
|
Wacht op update
|
Multiple sclerose (MS)
|
Toray Industries, Inc.
|
Fase I
|
BBT-012
|
langwerkend interferon bèta 1b, BBT-032
|
Wacht op update
|
Multiple sclerose (MS)
|
Bolder BioTechnology
|
Pre-klinisch
|
Interferon bèta biobetter
|
Interferon-β, ABN101
|
Wacht op update
|
Multiple sclerose (MS)
|
ABION, Inc.
|
Pre-klinisch
|